Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

What's new in Nicotine & Tobacco Research?

What's new in Nicotine & Tobacco Research? Nicotine & Tobacco Research (2000) 2, 15– 17 Edited by Richard Hebert ´ Review Article of these products must be tested by independent investigators. A preliminary test of Phillip Morris’ The Hunt for Drugs to Combat Withdrawal Accord® smoking system has been completed by ( ) Most smokers try to quit at one time or another, but only Buchhalter and Eissenberg p. 39 . They find the device 10– 20% are still not smoking after 1 year. The wanting. Intended to reduce second-hand smoke, the withdrawal symptoms that typically drive them back to Accord® consists of a handheld, puff-activated chamber smoking are rooted in the brain: cravings and negative that electronically heats the tobacco of specially emotional states such as depressed mood and stress. designed ‘cigarettes.’ The researchers tested the ( ) Watkins, Koob and Markou p. 19 have now assembled Accord® on 10 mildly dependent smokers of ‘light’ and what’s both known and hypothesized about nicotine’s ‘ultra-light’ cigarettes. Their regular brands decreased neurobiological effects on the brain and the con- craving and withdrawal after just one cigarette, while sequences of withdrawal from nicotine. This knowledge , using the Accord® once failed to decrease craving and they suggest, offers http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Nicotine and Tobacco Research Oxford University Press

What's new in Nicotine & Tobacco Research?

Nicotine and Tobacco Research , Volume 2 (1) – Feb 1, 2000

Loading next page...
 
/lp/oxford-university-press/what-s-new-in-nicotine-tobacco-research-PWbsDsFxI6

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
Oxford University Press
Copyright
© Published by Oxford University Press.
ISSN
1462-2203
eISSN
1469-994X
DOI
10.1080/14622200050011268
Publisher site
See Article on Publisher Site

Abstract

Nicotine & Tobacco Research (2000) 2, 15– 17 Edited by Richard Hebert ´ Review Article of these products must be tested by independent investigators. A preliminary test of Phillip Morris’ The Hunt for Drugs to Combat Withdrawal Accord® smoking system has been completed by ( ) Most smokers try to quit at one time or another, but only Buchhalter and Eissenberg p. 39 . They find the device 10– 20% are still not smoking after 1 year. The wanting. Intended to reduce second-hand smoke, the withdrawal symptoms that typically drive them back to Accord® consists of a handheld, puff-activated chamber smoking are rooted in the brain: cravings and negative that electronically heats the tobacco of specially emotional states such as depressed mood and stress. designed ‘cigarettes.’ The researchers tested the ( ) Watkins, Koob and Markou p. 19 have now assembled Accord® on 10 mildly dependent smokers of ‘light’ and what’s both known and hypothesized about nicotine’s ‘ultra-light’ cigarettes. Their regular brands decreased neurobiological effects on the brain and the con- craving and withdrawal after just one cigarette, while sequences of withdrawal from nicotine. This knowledge , using the Accord® once failed to decrease craving and they suggest, offers

Journal

Nicotine and Tobacco ResearchOxford University Press

Published: Feb 1, 2000

There are no references for this article.